Laboratory for Sol-Gel, Institute of Materials Science, NCSR Demokritos, 153 10 Aghia Paraskevi Attikis, Greece.
Int J Pharm. 2012 May 30;428(1-2):134-42. doi: 10.1016/j.ijpharm.2012.02.030. Epub 2012 Feb 28.
In the current study, poly lactic acid (PLA) modified hollow crosslinked poly(hydroxyethyl methacrylate) (PHEMA) microspheres have been prepared, in order to obtain a stimulus-responsive, biocompatible carrier with sustained drug release properties. The synthetical process consisted of the preparation of poly(methacrylic acid)@poly(hydroxyethyl methacrylate-co-N,N'-methylene bis(acrylamide)) microspheres by a two stage distillation-precipitation polymerization technique using 2,2'-azobisisobutyronitrile as initiator. Following core removal, a PLA coating of the microspheres was formed, after ring opening polymerization of DL-lactide, attributing the initiator's role to the active hydroxyl groups of PHEMA. The anticancer drug daunorubicin (DNR) was selected for the study of loading and release behavior of the coated microspheres. The loading capacity of the PLA modified microspheres was found to be four times higher than that of the parent ones (16% compared to 4%). This coated microspherical carrier exhibited a moderate pH responsive drug release behavior due to the pH dependent water uptake of PHEMA, and PLA hydrolysis. The in vitro cytotoxicity of both the parent and the DNR-loaded or empty modified hollow microspheres has been also examined on MCF-7 breast cancer cells. The results showed that although the empty microspheres were moderately cytotoxic, the DNR-loaded microspheres had more potent anti-tumor effect than the free drug. Therefore, the prepared coated microspheres are interesting drug delivery systems.
在当前的研究中,制备了聚乳酸(PLA)修饰的中空交联聚(羟乙基甲基丙烯酸酯)(PHEMA)微球,以获得具有刺激响应性、生物相容性和持续药物释放性能的载体。合成过程包括使用 2,2'-偶氮二异丁腈作为引发剂,通过两步蒸馏沉淀聚合技术制备聚(甲基丙烯酸)@聚(羟乙基甲基丙烯酸酯-co-N,N'-亚甲基双(丙烯酰胺))微球。在核去除后,通过 DL-丙交酯的开环聚合形成 PLA 涂层,赋予引发剂的作用是 PHEMA 的活性羟基。选择抗癌药物柔红霉素(DNR)来研究涂层微球的负载和释放行为。PLA 修饰的微球的载药量比母体微球高四倍(16%比 4%)。由于 PHEMA 的 pH 依赖性吸水和 PLA 水解,这种涂层的空心微球载体表现出适度的 pH 响应性药物释放行为。还在 MCF-7 乳腺癌细胞上研究了母体和载有 DNR 或空的改性空心微球的体外细胞毒性。结果表明,尽管空微球具有中度细胞毒性,但载有 DNR 的微球比游离药物具有更强的抗肿瘤作用。因此,所制备的涂层微球是有趣的药物递送系统。